Urbano
Anido Herranz
Pfizer (United States)
Nueva York, Estados UnidosPublicacións en colaboración con investigadores/as de Pfizer (United States) (1)
2022
-
Clinical Factors Associated With Long-Term Benefit in Patients With Metastatic Renal Cell Carcinoma Treated With Axitinib: Real-World AXILONG Study
Clinical Genitourinary Cancer, Vol. 20, Núm. 1, pp. 25-34